A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer

V Jain, H Kumar, HV Anod, P Chand, NV Gupta… - Journal of Controlled …, 2020 - Elsevier
Breast cancer (BC) is one of the most prevalent cancers in women. Triple-negative breast
cancer (TNBC) in which the three major receptors ie estrogen receptor (ER), progesterone …

Polymeric micelles: A novel drug delivery system for the treatment of breast cancer

A Chaudhuri, K Ramesh, DN Kumar, D Dehari… - Journal of Drug Delivery …, 2022 - Elsevier
Polymeric micelles have acquired quite an interest as an innovative drug delivery system for
the diagnosis and treatment of breast cancer, as they endeavour numerous benefits over the …

Oxaliplatin delivery via chitosan/vitamin E conjugate micelles for improved efficacy and MDR-reversal in breast cancer

AM Itoo, M Paul, B Ghosh, S Biswas - Carbohydrate Polymers, 2022 - Elsevier
A bioinspired chitosan/vitamin E conjugate (Ch/VES, 1: 4) was synthesized, optimized based
on chitosan's molecular weight (15, 300 kDa), and was assembled to entrap oxaliplatin …

Aptamer-grafted, cell membrane-coated dendrimer loaded with doxorubicin as a targeted nanosystem against epithelial cellular adhesion molecule (EpCAM) for triple …

A Sheikh, MAS Abourehab, AS Tulbah… - Journal of Drug Delivery …, 2023 - Elsevier
The major issue associated with chemotherapeutics is the non-specific distribution,
extended range of toxicity, and low intratumoral accumulation. Targeted therapy using …

CBD loaded microparticles as a potential formulation to improve paclitaxel and doxorubicin-based chemotherapy in breast cancer

AI Fraguas-Sánchez, A Fernández-Carballido… - International journal of …, 2020 - Elsevier
Cannabidiol (CBD) has emerged as a potential agent for breast cancer management. In this
work, the potential use of cannabidiol in solution (CBD sol) and encapsulated in polymeric …

Nanotherapeutics in Women's Health Emerging Nanotechnologies for Triple‐Negative Breast Cancer Treatment

S Torres Quintas, A Canha‐Borges, MJ Oliveira… - Small, 2024 - Wiley Online Library
Breast cancer appears as the major cause of cancer‐related deaths in women, with more
than 2 260 000 cases reported worldwide in 2020, resulting in 684 996 deaths. Triple …

Nanotechnology revolutionises breast cancer treatment: harnessing lipid-based nanocarriers to combat cancer cells

F Fatima Qizilbash, A Sartaj, Z Qamar… - Journal of Drug …, 2023 - Taylor & Francis
One of the most common cancers that occur in females is breast cancer. Despite the
significant leaps and bounds that have been made in treatment of breast cancer, the disease …

Cannabidiol-loaded nanocarriers and their therapeutic applications

E Assadpour, A Rezaei, SS Das, BV Krishna Rao… - Pharmaceuticals, 2023 - mdpi.com
Cannabidiol (CBD), one of the most promising constituents isolated from Cannabis sativa,
exhibits diverse pharmacological actions. However, the applications of CBD are restricted …

Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists

E Wouters, J Walraed, SD Banister, CP Stove - Biochemical pharmacology, 2019 - Elsevier
Abstract Cannabinoid receptors type 1 (CB 1) and type 2 (CB 2) are promising targets for a
number of diseases, including obesity, neuropathic pain, and multiple sclerosis, among …

Cannabinoids in medicine: cancer, immunity, and microbial diseases

P Śledziński, A Nowak-Terpiłowska… - International journal of …, 2020 - mdpi.com
Recently, there has been a growing interest in the medical applications of Cannabis plants.
They owe their unique properties to a group of secondary metabolites known as …